公开(公告)号：US09018390B2

公开(公告)日：2015-04-28

申请号：US13919027

申请日：2013-06-17

Applicant: Bristol-Myers Squibb Company

Inventor： Carol Bachand ,  Makonen Belema ,  Daniel H. Deon ,  Andrew C. Good ,  Jason Goodrich ,  Clint A. James ,  Rico Lavoie ,  Omar D. Lopez ,  Alain Martel ,  Nicholas A. Meanwell ,  Van N. Nguyen ,  Jeffrey Lee Romine ,  Edward H. Ruediger ,  Lawrence B. Snyder ,  Denis R. St. Laurent ,  Fukang Yang ,  David R. Langley ,  Lawrence G. Hamann

IPC: C07D233/00 ,  C07D233/02 ,  A01N43/50 ,  A61K31/415 ,  C07D403/14 ,  A61K31/4178 ,  A61K31/4545 ,  A61K31/5377 ,  A61K31/695 ,  A61K45/06 ,  C07D401/14 ,  C07F7/10

CPC classification number: C07D403/14 ,  A61K31/4178 ,  A61K31/4545 ,  A61K31/5377 ,  A61K31/695 ,  A61K45/06 ,  C07D401/14 ,  C07F7/10

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract translation: 本公开涉及用于治疗丙型肝炎病毒（HCV）感染的化合物，组合物和方法。 还公开了含有这些化合物的药物组合物和使用这些化合物治疗HCV感染的方法。

公开(公告)号：US20150011754A1

公开(公告)日：2015-01-08

申请号：US14488990

申请日：2014-09-17

Applicant: Bristol-Myers Squibb Company

Inventor： Carol Bachand ,  Makonen Belema ,  Daniel H. Deon ,  Andrew C. Good ,  Jason Goodrich ,  Clint A. James ,  Rico Lavoie ,  Omar D. Lopez ,  Alain Martel ,  Nicholas A. Meanwell ,  Van N. Nguyen ,  Jeffrey Lee Romine ,  Edward H. Ruediger ,  Lawrence B. Snyder ,  Denis R. St. Laurent ,  Fukang Yang ,  David R. Langley ,  Lawrence G. Hamann

IPC: C07D413/14 ,  C07D401/14 ,  C07D233/64 ,  C07D403/14 ,  C07D405/14

CPC classification number: C07D233/64 ,  A61K31/4178 ,  A61K45/06 ,  C07D207/16 ,  C07D401/14 ,  C07D403/14 ,  C07D405/14 ,  C07D409/14 ,  C07D413/14 ,  C07D417/14 ,  C07F5/025 ,  C07F7/0812

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

公开(公告)号：US20140017195A1

公开(公告)日：2014-01-16

申请号：US14021686

申请日：2013-09-09

Applicant: Bristol-Myers Squibb Company

Inventor： Carol Bachand ,  Makonen Belema ,  Daniel H. Deon ,  Andrew C. Good ,  Jason Goodrich ,  Clint A. James ,  Rico Lavole ,  Omar D. Lopez ,  Alain Martel ,  Nicolas A. Meanwell ,  Van N. Nguyen ,  Jeffrey Lee Romine ,  Edward H. Ruediger ,  Lawrence B. Snyder ,  Denis R. St. Laurent ,  Fukang Yang ,  David R. Langley ,  Gan Wang ,  Lawrence G. Hamann

IPC: A61K31/506 ,  A61K31/4178 ,  C07D417/14 ,  A61K31/427 ,  A61K31/13 ,  A61K38/20 ,  A61K38/21 ,  A61K31/7105 ,  A61K31/4745 ,  A61K31/7056 ,  C07D403/14 ,  C07D405/14

CPC classification number: A61K31/506 ,  A61K31/13 ,  A61K31/4178 ,  A61K31/427 ,  A61K31/4745 ,  A61K31/7056 ,  A61K31/7105 ,  A61K38/2013 ,  A61K38/204 ,  A61K38/208 ,  A61K38/21 ,  A61K38/212 ,  C07D401/14 ,  C07D403/14 ,  C07D405/14 ,  C07D417/14

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.